HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth S Rosenthal Selected Research

CEL 2000

4/2010CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth S Rosenthal Research Topics

Disease

3Rheumatoid Arthritis
01/2017 - 04/2010
2Arthritis (Polyarthritis)
01/2017 - 04/2010
2Disease Progression
01/2017 - 04/2010
1Autoimmune Diseases (Autoimmune Disease)
06/2015
1Experimental Arthritis
04/2010
1Communicable Diseases (Infectious Diseases)
06/2004
1Malaria
06/2004

Drug/Important Bio-Agent (IBA)

3EpitopesIBA
01/2017 - 04/2010
3LigandsIBA
01/2017 - 04/2010
3VaccinesIBA
01/2017 - 04/2010
2CytokinesIBA
06/2015 - 04/2010
2Peptides (Polypeptides)IBA
04/2010 - 06/2004
1Proteoglycans (Proteoglycan)IBA
01/2017
1AutoantigensIBA
06/2015
1Collagen Type II (Type II Collagen)IBA
04/2010
1CEL 2000IBA
04/2010
1Etanercept (Enbrel)FDA Link
04/2010
1Conjugate VaccinesIBA
04/2010
1ChemokinesIBA
04/2010
1DefensinsIBA
06/2004
1Imiquimod (Aldara)FDA LinkGeneric
06/2004
1CPG-oligonucleotideIBA
06/2004
1Cancer VaccinesIBA
06/2004
1Immunoglobulin G (IgG)IBA
06/2004

Therapy/Procedure

1Therapeutics
04/2010